Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the α2B-adrenoceptor

被引:13
作者
Desai, Aarti N. [1 ]
Salim, Samina [1 ]
Standifer, Kelly M. [1 ]
Eikenburg, Douglas C. [1 ]
机构
[1] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA
关键词
D O I
10.1124/jpet.105.098996
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Increasing the cellular levels of G protein-coupled receptor kinase (GRK) 2 or GRK3 renders the alpha(2B)-adrenoceptor (AR) more sensitive to agonist-induced down-regulation (J Pharmacol Exp Ther 312: 767 - 773, 2005). However, an absolute requirement of GRK3 and GRK2 for alpha(2B)-AR down-regulation is controversial. In this study, using NG108 cells (endogenous alpha(2B)-AR), we provide strong evidence for a critical role of both GRK3 and GRK2 in down-regulation of the alpha(2B)-AR. Pretreatment of NG108 cells with 20 mu M epinephrine (EPI) begins down-regulating the alpha(2B)-AR by 2 h. The translocation of GRK3 and GRK2 to the membrane peaks at 30 min, decreasing by 1 h. Although these results may implicate GRK3 and GRK2 in alpha(2B)-AR down-regulation, significant receptor down-regulation is not observed until 2 h, after GRK3 and GRK2 translocation has peaked and is declining. To more directly establish a role for GRK3 and GRK2 in alpha(2B)-AR down-regulation, NG108 cells were transfected to express GRK3ct, which binds to liberated G(beta gamma) subunits, preventing GRK3 and GRK2 translocation to the membrane. Overexpression of GRK3ct prevented not only the translocation of GRK3 and GRK2 but also the down-regulation of the alpha(2B)-AR caused by 24-h pretreatment with 20 mu M EPI. Taken together, these data provide direct evidence for a role of GRK3 and GRK2 in the down- regulation of the alpha(2B)-AR and contribute significantly to the increasing evidence in the literature for a pivotal role of GRKs in modulating the agonistinduced down- regulation of the alpha(2)-AR.
引用
收藏
页码:1027 / 1035
页数:9
相关论文
共 38 条
[1]
Desensitization of α2A-adrenoceptor signalling by modest levels of adrenaline is facilitated by β2-adrenoceptor-dependent GRK3 up-regulation [J].
Bawa, T ;
Altememi, GF ;
Eikenburg, DC ;
Standifer, KM .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (05) :921-931
[2]
FUNCTIONAL DESENSITIZATION OF THE ISOLATED BETA-ADRENERGIC-RECEPTOR BY THE BETA-ADRENERGIC-RECEPTOR KINASE - POTENTIAL ROLE OF AN ANALOG OF THE RETINAL PROTEIN ARRESTIN (48-KDA PROTEIN) [J].
BENOVIC, JL ;
KUHN, H ;
WEYAND, I ;
CODINA, J ;
CARON, MG ;
LEFKOWITZ, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :8879-8882
[3]
BETA-ADRENERGIC-RECEPTOR KINASE - IDENTIFICATION OF A NOVEL PROTEIN-KINASE THAT PHOSPHORYLATES THE AGONIST-OCCUPIED FORM OF THE RECEPTOR [J].
BENOVIC, JL ;
STRASSER, RH ;
CARON, MG ;
LEFKOWITZ, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (09) :2797-2801
[4]
Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the μ-opioid receptor [J].
Burd, AL ;
El-Kouhen, R ;
Erickson, LJ ;
Loh, HH ;
Law, PY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) :34488-34495
[5]
BYLUND DB, 1988, J PHARMACOL EXP THER, V245, P600
[6]
Homologous regulation of the α2C-adrenoceptor subtype in human hepatocarcinoma, HepG2 [J].
Cayla, C ;
Schaak, S ;
Roquelaine, C ;
Gales, C ;
Quinchon, F ;
Paris, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (01) :69-78
[7]
DESENSITIZATION OF ALPHA-2-ADRENERGIC RECEPTORS IN NG-108 15 CELLS BY (-)-ADRENALINE AND PHORBOL 12-MYRISTATE 13-ACETATE [J].
CONVENTS, A ;
DEBACKER, JP ;
ANDRE, C ;
VAUQUELIN, G .
BIOCHEMICAL JOURNAL, 1989, 262 (01) :245-251
[8]
Subtype-specific intracellular trafficking of alpha(2)-adrenergic receptors [J].
Daunt, DA ;
Hurt, C ;
Hein, L ;
Kallio, J ;
Feng, F ;
Kobilka, BK .
MOLECULAR PHARMACOLOGY, 1997, 51 (05) :711-720
[9]
Cellular G protein-coupled receptor kinase levels regulate sensitivity of the α2B-adrenergic receptor to undergo agonist-induced down-regulation [J].
Desai, AN ;
Standifer, KM ;
Eikenburg, DC .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (02) :767-773
[10]
Simultaneous α2B- and β2-adrenoceptor activation sensitizes the α2B-adrenoceptor for agonist-induced down-regulation [J].
Desai, AN ;
Standifer, KM ;
Eikenburg, DC .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (02) :794-802